Urenco UK Limited

Active01144899 Private limited company

What Urenco UK say about themselves

“We play an essential role in the generation of reliable, low carbon electricity for consumers worldwide by supplying enriched uranium to the nuclear industry.”

— from urenco.com

Incorporated: 12 November 1973 (52 years)
Previously known as: Urenco (Capenhurst) Limited (until 30 May 2008)
BNFL Enrichment (Operations) Limited (until 23 June 1992)
Industry: Manufacture of other inorganic basic chemicals (20130)
Directors: Andrew John Cottrell
Michael Ashley Peers
Bridget Sparrow
all 4 directors
Owned by: Urenco Enrichment Company Limited
Accounts type: Full
Address: Capenhurst Works
Capenhurst
Chester
CH1 6ER

Website & contact details

Website: urenco.com

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 26 January 2027
Last conf. stmt: 12 January 2026

Officers 5 active

Officer details are public data from the Companies House register.

Cottrell, Andrew John

Director · Appointed 31 March 2025

Also at Urenco Chemplants Limited, Urenco Nuclear Stewardship Limited · more companies

British

Born July 1972 (54)

Straver, Luke

Secretary · Appointed 1 August 2024

Peers, Michael Ashley

Director · Appointed 4 June 2024

British

Born October 1969 (57)

Sparrow, Bridget

Director · Appointed 4 June 2024

Also at Urenco Chemplants Limited, Urenco Nuclear Stewardship Limited

Irish

Born October 1963 (63)

Chater, Christopher Roy

Director · Appointed 16 October 2012

Also at Enrichment Technology Company Limited, Urenco Chemplants Limited, Urenco Nuclear Stewardship Limited

British

Born March 1968 (58)

Officer history (33 former)

31 March 2025

Appointed Cottrell, Andrew John as Director

31 March 2025

Resigned Annan, Douglas Stuart, Dr as Director

1 August 2024

Appointed Straver, Luke as Secretary

4 June 2024

Resigned Lloyd, Christopher as Director

4 June 2024

Appointed Peers, Michael Ashley as Director

4 June 2024

Appointed Sparrow, Bridget as Director

4 June 2024

Resigned Sexton, David Eric as Director

30 June 2023

Resigned Simmonds, Lynton John as Director

1 December 2022

Appointed Annan, Douglas Stuart, Dr as Director

31 August 2021

Appointed Lloyd, Christopher as Director

31 August 2021

Resigned Oakley, Matthew John as Director

25 June 2021

Resigned Newby, Sarah as Secretary

3 August 2020

Appointed Oakley, Matthew John as Director

3 August 2020

Appointed Sexton, David Eric as Director

3 August 2020

Resigned Schucht, Boris Benjamin as Director

1 July 2019

Appointed Schucht, Boris Benjamin as Director

31 March 2019

Resigned Haeberle, Thomas Michael as Director

8 June 2018

Appointed Simmonds, Lynton John as Director

8 June 2018

Resigned Pearson, Martin Bryan as Director

15 May 2017

Resigned Carrick, Richard James as Director

26 September 2016

Appointed Pearson, Martin Bryan as Director

1 January 2016

Appointed Haeberle, Thomas Michael as Director

1 January 2016

Resigned Engelbrecht, Helmut Heinrich August, Dr as Director

7 September 2015

Resigned Bowen, Simon Christopher as Director

21 July 2015

Appointed Carrick, Richard James as Director

28 April 2015

Resigned Smith, Gregory O'Dee as Director

27 March 2014

Resigned Lunn, Mark Henry Bernard as Director

11 March 2014

Appointed Smith, Gregory O'Dee as Director

16 October 2012

Appointed Lunn, Mark Henry Bernard as Director

16 October 2012

Appointed Chater, Christopher Roy as Director

16 October 2012

Resigned Stenhoff, Andrew Paul as Director

5 April 2012

Resigned Bucksey, Nicholas as Secretary

5 April 2012

Appointed Newby, Sarah as Secretary

1 August 2011

Appointed Bucksey, Nicholas as Secretary

1 August 2011

Resigned Newby Smith, Sarah Louise as Secretary

1 February 2011

Appointed Bowen, Simon Christopher as Director

1 February 2011

Resigned Harding, Paul James Cooper, Dr as Director

18 March 2009

Appointed Stenhoff, Andrew Paul as Director

1 October 2007

Resigned Graves, Sheila May as Secretary

1 October 2007

Resigned Bryning, David as Director

1 October 2007

Appointed Newby Smith, Sarah Louise as Secretary

16 December 2004

Resigned Upson, Patrick Charles, Dr as Director

16 April 2004

Appointed Engelbrecht, Helmut Heinrich August, Dr as Director

30 September 2003

Resigned Gremmen, Theodorus Marenus Maria as Director

30 September 2003

Resigned Lenders, Maurice Francois Marie Louis as Director

13 February 2003

Appointed Harding, Paul James Cooper, Dr as Director

31 January 2003

Resigned Hooley, Stephen Roger, Dr as Director

31 December 2002

Resigned Messer, Klaus-Peter, Dr as Director

23 November 1999

Appointed Bryning, David as Director

1 January 1999

Appointed Lenders, Maurice Francois Marie Louis as Director

31 December 1998

Resigned Paleit, Jurgen Alfred as Director

30 January 1996

Appointed Graves, Sheila May as Secretary

30 January 1996

Resigned Kehoe, Richard Brian, Dr as Secretary

10 October 1995

Appointed Gremmen, Theodorus Marenus Maria as Director

31 May 1995

Resigned Van Den Burg, Hendrik Jan, Doctor as Director

23 September 1993

Appointed Hooley, Stephen Roger, Dr as Director

10 September 1993

Appointed Kehoe, Richard Brian, Dr as Secretary

10 September 1993

Resigned Shuttleworth, Alvin Joseph as Secretary

7 September 1993

Appointed Paleit, Jurgen Alfred as Director

7 September 1993

Appointed Upson, Patrick Charles, Dr as Director

7 September 1993

Appointed Van Den Burg, Hendrik Jan, Doctor as Director

7 September 1993

Resigned Lorimer, Andrew James as Director

7 September 1993

Resigned Hooley, Stephen Roger, Dr as Director

7 September 1993

Resigned Jackson, Kenneth George as Director

7 September 1993

Resigned Watts, Graham Leonard as Director

4 May 1993

Appointed Messer, Klaus-Peter, Dr as Director

5 April 1993

Appointed Lorimer, Andrew James as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Urenco Enrichment Company Limited

Corporate entity · Notified 25 July 2016

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Company

Reg. no. 04696557

Group structure 8 companies

Ownership group derived from the Companies House PSC register

Urenco Limited

Urenco Chemplants Limited Owns 75–100% of shares

Urenco Enrichment Company Limited Owns 75–100% of shares

Urenco UK Limited This company Owns 75–100% of shares

Urenco Funding Limited Owns 75–100% of shares

Urenco Nuclear Stewardship Limited Owns 75–100% of shares

Urenco Usa Holdings Limited Owns 75–100% of shares

Urenco Finance UK Limited Owns 75–100% of shares

Filings 201

Date	Description	Made Up To	Pages	PDF
26 May 2026	Statement of capital following an allotment of shares
21 May 2026	Insolvency filing
21 May 2026	Share capital filing
21 May 2026	Statement of capital
21 May 2026	Resolutions